VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,010 | +1385.2% | 428 | +3790.9% | 0.00% | – |
| Q2 2023 | $270 | +5.5% | 11 | 0.0% | 0.00% | – |
| Q1 2023 | $256 | -86.3% | 11 | -85.1% | 0.00% | – |
| Q4 2022 | $1,873 | -62.5% | 74 | -69.5% | 0.00% | -100.0% |
| Q3 2022 | $5,000 | +66.7% | 243 | +133.7% | 0.00% | – |
| Q2 2022 | $3,000 | – | 104 | +550.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 16 | -33.3% | 0.00% | – |
| Q4 2021 | $1,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |